HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial

NCT04653818 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatitis C
Neoplasm Recurrence
Treatment Complication

Interventions

DRUG: Velpatasvir/Sofosbuvir

Sponsor

Alexandria University